HIF1A and lung cancer: These results replicated our findings in monolayer NSCLC culture experiments, thus showing the potential of miR‐210‐3p and HIF‐1A inhibitors in preventing hypoxia‐induced inhibition of monocyte infiltration in the lung tumor microenvironment and the growth of lung cancer spheroids.